The decision hands Moderna its second-only product approval to date after its Covid jab, which has generated more than $40bn in revenue. Its blockbuster Covid shot propelled the Boston-based ...
Synopsys VC Verification IP (VIP) for Fibre Channel is designed to thoroughly verify Fibre Channel designs using both random and ...
Moderna Inc. gained US approval for its RSV vaccine in older adults, giving the biotech company a second product as it seeks to move beyond its reliance on the fading market for Covid-19 shots ...
Like its COVID shot ... One case of GBS was reported by GSK in clinical testing, while Pfizer reported two. Moderna has not ...
Moderna Inc ... beyond its reliance on the fading market for COVID-19 shots. The U.S. Food and Drug Administration approved ...
Moderna Inc.’s respiratory syncytial virus vaccine for older adults received U.S. regulatory approval, the company said Friday, marking the first time a messenger RNA vaccine has been approved ...
The Cambridge, Massachusetts-based company has been banking on its experimental shots to make up for vastly lower demand for its Spikevax COVID-19 vaccine, its only marketed product. Moderna's RSV ...
A researcher at the Moderna headquarters in Cambridge, Mass. (Adam Glanzman/Bloomberg News) Moderna, the biotech that rose to fame for making one of the world’s first Covid-19 vaccines ...
Biotech firm Moderna (Nasdaq: MRNA) has won US Food and Drug Administration (FDA) approval for mRESVIA (mRNA-1345), an mRNA ...
Don't have an account yet? To access the premium content on InsuranceERM, you must first sign in to your account. Not registered ...